Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?

被引：2
|
作者：
Poletajew, Slawomir [1 ]
Krajewski, Wojciech [2 ]
Kryst, Piotr [1 ]
机构：
[1] Ctr Postgrad Med Educ, Dept Urol 2, 80 Ceglowska St, PL-00809 Warsaw, Poland
[2] Wroclaw Med Univ, Dept Urol & Oncol Urol, Wroclaw, Poland
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2020年 / 9卷 / 06期
关键词：
CISPLATIN-INELIGIBLE PATIENTS; PD-1; BLOCKADE; UROTHELIAL CARCINOMA; CLINICAL-RESPONSE; SOLID TUMORS; SINGLE-ARM; MULTICENTER; SENSITIVITY; EXPRESSION; GUIDELINES;
D O I：
10.21037/tau-20-907
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：2479 / 2482
页数：4
相关论文
共 50 条
  • [21] Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review
    Colombo, Alfredo
    Cordio, Stefano
    Porretto, Concetta Maria
    INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION, 2024, 13 (03): : 74 - 81
  • [22] Immuno-related adverse events from check-point inhibitors during immune-therapy for cancer. Imaging findings
    Sandomenico, F.
    De Rosa, G.
    Pizza, S.
    Catalano, O.
    Setola, S.
    Simeone, E.
    Festino, L.
    Grimaldi, A.
    Vanella, V.
    Petrillo, A.
    Ascierto, P.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S22 - S22
  • [23] Morphological spectrum of immune check-point inhibitor therapy-associated gastritis
    Johncilla, Melanie
    Grover, Shilpa
    Zhang, Xuchen
    Jain, Dhanpat
    Srivastava, Amitabh
    HISTOPATHOLOGY, 2020, 76 (04) : 531 - 539
  • [24] Unlocking the potential with the use of check-point inhibitor immunotherapies in metastatic prostate cancer
    Revannasiddaiah, Swaroop
    Gupta, Ishu
    Devadas, Santhosh Kumar
    CHINESE CLINICAL ONCOLOGY, 2019, 8
  • [25] Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors
    Stucci, Luigia Stefania
    D'Oronzo, Stella
    Tucci, Marco
    Macerollo, Antonella
    Ribero, Simone
    Spagnolo, Francesco
    Marra, Elena
    Picasso, Virginia
    Orgiano, Laura
    Marconcini, Riccardo
    De Rosa, Francesco
    Di Guardo, Lorenza
    Galli, Giulia
    Gandini, Sara
    Palmirotta, Raffaele
    Palmieri, Giuseppe
    Queirolo, Paola
    Silvestris, Francesco
    CANCER TREATMENT REVIEWS, 2018, 69 : 21 - 28
  • [26] Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer
    Genova, Carlo
    Rossi, Giovanni
    Rijavec, Erika
    Biello, Federica
    Barletta, Giulia
    Tagliamento, Marco
    Grossi, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (05) : 573 - 585
  • [27] POTENTIATING THE EFFICACY OF IMMUNE CHECK-POINT INHIBITORS IN GLIOBLASTOMA BY INHIBITION OF CXCL12
    Makranz, Chen Cam-El
    Huguely, Caitlin
    Haynes, Tuesday
    Briceno, Nicole
    Zhang, Meili
    Davis, Dionne
    Song, Hua
    Zhang, Wei
    Gilbert, Mark
    Watanabe, Masashi
    NEURO-ONCOLOGY, 2024, 26
  • [28] Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC)
    Sherman, Shira
    Rotem, Ofer
    Shochat, Tzippy
    Zer, Alona
    Moore, Assaf
    Dudnik, Elizabeth
    LUNG CANCER, 2020, 143 : 40 - 46
  • [29] Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumours of lung (LCNET)
    Sherman, S.
    Rotem, O.
    Zer, A.
    Shochat, T.
    Dudnik, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Immune checkpoint inhibitors for metastatic bladder cancer
    Massari, Francesco
    Di Nunno, Vincenzo
    Cubelli, Marta
    Santoni, Matteo
    Fiorentino, Michelangelo
    Montironi, Rodolfo
    Cheng, Liang
    Lopez-Beltran, Anto
    Battelli, Nicola
    Ardizzoni, Andrea
    CANCER TREATMENT REVIEWS, 2018, 64 : 11 - 20
12345